WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 412
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 522

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 53'259  52'797  52'351  51'931  51'540  48'453  42'123  34'475 
Births 917  922  927  931  935  1'009  1'129  1'245 
Surviving infants 872  877  881  884  887  947  1'043  1'126 
Pop. less than 5 years 4'406  4'434  4'440  4'416  4'415  4'856  5'318  5'292 
Pop. less than 15 years 13'267  13'367  13'461  13'539  13'636  14'894  15'868  14'170 
Female 15-49 years 15'579  15'463  15'348  15'240  15'134  13'880  10'704  8'133 

Number of reported case

(Click for retrospective incidence data for Myanmar)
Diphtheria 38  19  19  17  181  830 
Japanese encephalitis 14  20  18 
Measles 1'010  2'175  2'046  190  329  845  7'900  21'457 
Mumps
Pertussis 14  55  7'882  26'878 
Polio* 44  47  244 
Rubella 23  21  103  11  13 
Rubella (CRS)
Tetanus (neonatal) 39  29  32  19  34  41  27  124 
Tetanus (total) 73  75  178  96  229  312  769  2'423 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Myanmar)
Vaccine year result method % card seen                                                
BCG 2008  98  MICS   96  86  87  93  93  93  88  67 
DTP1 2008  98  MICS   96  90  89  88  93  93  87 
DTP3 2008  98  MICS   96  75  84  86  90  90  82  69 
HepB_BD         
HepB3 2008  98  MICS   96  72  38  90  90 
Hib3          72 
JapEnc         
MCV 2008  98  MICS   96  86  84  88  88  87  84  68 
MCV2          80  80  75  65 
PCV1         
PCV3         
Pol3 2008  98  MICS   96  76  87  90  90  90  86  69 
Rota1         
Rota_last         
Rubella1         
TT2plus 1999  78  MICS   52  81  85  87  86  94  81  56 
PAB         
VAD1          95  95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Myanmar)
BCG 86  87  93  93  93  88  95 
DTP1 90  89  88  93  93  87  96  22 
DTP3 75  84  84  90  90  82  88 
HepB3 72  55  38  90  90 
HepB_BD
Hib3 72 
MCV 86  84  88  88  87  84  68 
MCV2 80  80  75  65 
PAB 87  93  93  93  93  79  62 
PnC3
Pol3 76  87  90  90  90  88  88 
Rota_last

Number of districts in the country 330  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 12
From 80 to 89% 33
From 50 to 79% 45
Less than 50% 8
Proportion of districts
not reporting DTP3 coverage
2
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6 months;
HepB birth; Yes
Measles 9, 18 months; Yes
OPV 2, 4. 6 months; Yes
TT 1st contact pregnancy; +4 weeks; Yes
VitaminA 6-59, 13-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016    2012-2016  2007-2011  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 330  324  330  319  300  325  325 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 330  330  330  325  325  325  325 
Nº districts with DTP3 coverage >=80% number 147  214  252  284  289  225  103 
% of districts with DTP3 coverage >=80% From 0 to 100% 45  65  76  87  89  69  32 
Nº districts with measles (MCV1) coverage >=95% number 86  74  81  81  62  56   
% of districts with MCV1 coverage >=95% From 0 to 100% 26  22  25  25  19  17   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 45  56           

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.